Log in to save to my catalogue

Cellular glycan modification by B3GAT1 broadly restricts influenza virus infection

Cellular glycan modification by B3GAT1 broadly restricts influenza virus infection

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_421acf3c2de24f58bda9a6d24454f5bd

Cellular glycan modification by B3GAT1 broadly restricts influenza virus infection

About this item

Full title

Cellular glycan modification by B3GAT1 broadly restricts influenza virus infection

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2022-10, Vol.13 (1), p.6456-6456, Article 6456

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Communicable respiratory viral infections pose both epidemic and pandemic threats and broad-spectrum antiviral strategies could improve preparedness for these events. To discover host antiviral restriction factors that may act as suitable targets for the development of host-directed antiviral therapies, we here conduct a whole-genome CRISPR activat...

Alternative Titles

Full title

Cellular glycan modification by B3GAT1 broadly restricts influenza virus infection

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_421acf3c2de24f58bda9a6d24454f5bd

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_421acf3c2de24f58bda9a6d24454f5bd

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-022-34111-0

How to access this item